Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05353439
Title Testing of Tazemetostat in Combination With Topotecan and Pembrolizumab in Patients With Recurrent Small Cell Lung Cancer
Recruitment Suspended
Gender both
Phase Phase I
Variant Requirements No
Sponsors National Cancer Institute (NCI)
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Keck Medicine of USC Koreatown Los Angeles California 90020 United States Details
Los Angeles General Medical Center Los Angeles California 90033 United States Details
USC / Norris Comprehensive Cancer Center Los Angeles California 90033 United States Details
USC Norris Oncology/Hematology-Newport Beach Newport Beach California 92663 United States Details
MedStar Georgetown University Hospital Washington District of Columbia 20007 United States Details
Northwestern University Chicago Illinois 60611 United States Details
University of Kentucky/Markey Cancer Center Lexington Kentucky 40536 United States Details
Johns Hopkins University/Sidney Kimmel Cancer Center Baltimore Maryland 21287 United States Details
NCI - Center for Cancer Research Bethesda Maryland 20892 United States Details
Montefiore Medical Center-Einstein Campus Bronx New York 10461 United States Details
Montefiore Medical Center - Moses Campus Bronx New York 10467 United States Details
Wake Forest University Health Sciences Winston-Salem North Carolina 27157 United States Details
UT Southwestern/Simmons Cancer Center-Dallas Dallas Texas 75390 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field